
- Telehealth Visits
- Insurance plan information

Emmy Tian, OD
Optometry- Telehealth Visits
- Insurance plan information



Emmy Tian, OD
Optometry- Telehealth Visits
- Insurance plan information
On this page
About me
Emmy Tian is an optometrist who specializes in fitting contact lenses to improve eye function, comfort and appearance for patients. Conditions she treats include irregular astigmatism (abnormal curve to the eye that causes blurry vision), Stevens Johnson Syndrome, graft-versus-host disease, disfigured eyes, and conditions such as keratoconus, pellucid marginal degeneration and post-LASIK ectasia.
Tian earned her doctor of optometry degree at the UC Berkeley School of Optometry. She completed a residency in cornea and contact lenses at Southern California College of Optometry. Throughout her education and early career, she has won several merit-based awards, including the VSP Practice Excellence Scholarship, the GP Lens Institute Alumni Gift Award, and the Founders' Grant from the International Society of Contact Lens Specialists (ISCLS). She is an associate member of ISCLS and a fellow of the American Academy of Optometry.
Tian is originally from Reno, Nevada. Outside the clinic, she enjoys teaching herself new hobbies including hand lettering, embroidery and cross-stitching.
Education & training
Residency
- Optometry, Southern California College of Optometry
Degree
- OD, UC Berkeley School of Optometry
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%225615%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225615%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.